4F-benzoyl-TN14003 for the mobilisation of hematopoietic progenitor cells in view of transplantation
申请人:Biokine Therapeutics LTD.
公开号:EP3011961A1
公开(公告)日:2016-04-27
The present invention is directed to novel therapeutic uses of T- 140 analog peptides and compositions comprising same. Specifically, the invention provides compositions and methods useful for providing improved bone marrow transplantation and in the treatment of other conditions wherein bone marrow depletion or suppression is involved.
本发明涉及 T- 140 类似肽的新型治疗用途以及包含 T- 140 类似肽的组合物。具体地说,本发明提供的组合物和方法可用于改善骨髓移植和治疗涉及骨髓消耗或抑制的其他病症。